- STAT+: Roche drug sets new standard for KRAS-driven lung cancerBiotech's bull market, Vertex's gene therapy expansion, and more news from The ReadoutSTAT · 23d ago↗ source
- STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and moreU.S. judge blocked a Colorado state panel from placing a cap on the price of Amgen's blockbuster drug EnbrelSTAT · 23d ago↗ source
- STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drugA federal judge blocked a Colorado state panel from placing a cap on the price of Enbrel, a blockbuster drug sold by AmgenSTAT · 23d ago↗ source